Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

87 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Ustekinumab is associated with superior treatment persistence but not with higher remission rates versus vedolizumab in patients with refractory Crohn's disease: results from a multicentre cohort study.
Bacsur P, Matuz M, Resál T, Miheller P, Szamosi T, Schäfer E, Sarlós P, Iliás Á, Szántó K, Rutka M, Bálint A, Milassin Á, Fábián A, Bor R, Szepes Z, Molnár T, Farkas K. Bacsur P, et al. Among authors: ilias a. Therap Adv Gastroenterol. 2022 Dec 26;15:17562848221144349. doi: 10.1177/17562848221144349. eCollection 2022. Therap Adv Gastroenterol. 2022. PMID: 36600684 Free PMC article.
Quality of care indicators in inflammatory bowel disease in a tertiary referral center with open access and objective assessment policies.
Gonczi L, Kurti Z, Golovics PA, Lovasz BD, Menyhart O, Seres A, Sumegi LD, Gal A, Ilias A, Janos P, Gecse KB, Bessisow T, Afif W, Bitton A, Vegh Z, Lakatos PL. Gonczi L, et al. Among authors: ilias a. Dig Liver Dis. 2018 Jan;50(1):37-41. doi: 10.1016/j.dld.2017.09.137. Epub 2017 Oct 9. Dig Liver Dis. 2018. PMID: 29107471
Therapeutic preferences and outcomes in newly diagnosed patients with Crohn's diseases in the biological era in Hungary: a nationwide study based on the National Health Insurance Fund database.
Kurti Z, Ilias A, Gonczi L, Vegh Z, Fadgyas-Freyler P, Korponay G, Golovics PA, Lovasz BD, Lakatos PL. Kurti Z, et al. Among authors: ilias a. BMC Gastroenterol. 2018 Jan 30;18(1):23. doi: 10.1186/s12876-018-0746-6. BMC Gastroenterol. 2018. PMID: 29378524 Free PMC article.
Biosimilars in ulcerative colitis: When and for who?
Ilias A, Gonczi L, Kurti Z, Lakatos PL. Ilias A, et al. Best Pract Res Clin Gastroenterol. 2018 Feb-Apr;32-33:35-42. doi: 10.1016/j.bpg.2018.05.003. Epub 2018 May 26. Best Pract Res Clin Gastroenterol. 2018. PMID: 30060937 Review.
Reply.
Lovasz BD, Ilias A, Gonczi L, Lakatos PL. Lovasz BD, et al. Among authors: ilias a. J Gastrointestin Liver Dis. 2019 Mar;28(1):131-132. doi: 10.15403/jgld.2014.1121.281.rpl. J Gastrointestin Liver Dis. 2019. PMID: 30851185 No abstract available.
87 results